$XGN
EXAGEN INC. Stock $xgn

$xgn Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000127473723000103 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$13.77M	$13.42M
YoY Change	7.23%	-8.9%
Cost Of Revenue	$5.620M	$5.710M
YoY Change	-10.92%	-4.99%
Gross Profit	$8.145M	$7.706M
YoY Change	24.77%	-11.59%
Gross Profit Margin	59.17%	57.44%
Selling, General & Admin	$12.22M	$11.38M
YoY Change	-4.65%	-19.62%
% of Gross Profit	149.98%	147.61%
Research & Development	$1.076M	$1.400M
YoY Change	-60.16%	-41.23%
% of Gross Profit	13.21%	18.17%
Depreciation & Amortization	$507.0K	$600.0K
YoY Change	-2.5%	50.0%
% of Gross Profit	6.22%	7.79%
Operating Expenses	$13.29M	$12.78M
YoY Change	-14.32%	-22.73%
Operating Profit	-$5.147M	-$5.069M
YoY Change	-42.72%	-35.15%
Interest Expense	-$566.0K	$557.0K
YoY Change	-9.58%	-190.13%
% of Operating Profit
Other Income/Expense, Net	$173.0K	$211.0K
YoY Change	-64.03%	-37.76%
Pretax Income	-$5.540M	-$5.415M
YoY Change	-62.15%	-33.12%
Income Tax	$33.00K
% Of Pretax Income
Net Earnings	-$5.573M	-$5.415M
YoY Change	-61.17%	-33.12%
Net Earnings / Revenue	-40.49%	-40.36%
Basic Earnings Per Share		-$0.31
Diluted Earnings Per Share	-$0.31	-$0.31
COMMON SHARES
Basic Shares Outstanding	17.05M shares	16.86M shares
Diluted Shares Outstanding		17.69M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$36.49M	$28.45M
YoY Change	-41.51%	-58.59%
Cash & Equivalents	$36.50M	$28.45M
Short-Term Investments
Other Short-Term Assets	$2.871M	$2.239M
YoY Change	59.94%	-17.59%
Inventory
Prepaid Expenses
Receivables	$6.600M	$17.04M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$47.84M	$48.91M
YoY Change	-34.11%	-40.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.487M	$11.38M
YoY Change	3.54%	-15.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$616.0K	$638.0K
YoY Change	16.67%	8.87%
Total Long-Term Assets	$9.103M	$12.02M
YoY Change	-33.12%	-38.48%
TOTAL ASSETS
Total Short-Term Assets	$47.84M	$48.91M
Total Long-Term Assets	$9.103M	$12.02M
Total Assets	$56.94M	$60.93M
YoY Change	-33.96%	-40.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.131M	$1.657M
YoY Change	2.79%	-54.84%
Accrued Expenses	$7.531M	$7.063M
YoY Change	40.85%	-7.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$264.0K	$261.0K
YoY Change	38.95%	-64.25%
Total Short-Term Liabilities	$11.90M	$10.12M
YoY Change	23.68%	-10.7%
LONG-TERM LIABILITIES
Long-Term Debt	$19.23M	$19.19M
YoY Change	-33.17%	-31.47%
Other Long-Term Liabilities	$357.0K	$484.0K
YoY Change	-58.82%	-91.6%
Total Long-Term Liabilities	$19.59M	$19.68M
YoY Change	-33.92%	-41.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.90M	$10.12M
Total Long-Term Liabilities	$19.59M	$19.68M
Total Liabilities	$34.25M	$33.42M
YoY Change	-21.73%	-26.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$279.2M	-$273.6M
YoY Change	9.28%	13.43%
Common Stock	$17.00K	$17.00K
YoY Change	0.0%	6.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$22.69M	$27.50M
YoY Change
Total Liabilities & Shareholders Equity	$56.94M	$60.93M
YoY Change	-33.96%	-40.03%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$5.573M	-$5.415M
YoY Change	-61.17%	-33.12%
Depreciation, Depletion And Amortization	$507.0K	$600.0K
YoY Change	-2.5%	50.0%
Cash From Operating Activities	$8.349M	-$2.911M
YoY Change	-245.61%	-56.44%
INVESTING ACTIVITIES
Capital Expenditures	$106.0K	$2.000K
YoY Change	-73.89%	-100.23%
Acquisitions
YoY Change
Other Investing Activities	$22.00K	$2.000K
YoY Change
Cash From Investing Activities	-$84.00K	$0.00
YoY Change	-79.31%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-220.0K	-112.0K
YoY Change	27.17%	409.09%
NET CHANGE
Cash From Operating Activities	8.349M	-2.911M
Cash From Investing Activities	-84.00K	0.000
Cash From Financing Activities	-220.0K	-112.0K
Net Change In Cash	8.045M	-3.023M
YoY Change	-227.44%	-60.13%
FREE CASH FLOW
Cash From Operating Activities	$8.349M	-$2.911M
Capital Expenditures	$106.0K	$2.000K
Free Cash Flow	$8.243M	-$2.913M
YoY Change	-234.25%	-49.8%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Interest Expense InterestExpense	1769000	usd
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2022Q3	us-gaap	Interest Expense InterestExpense	618000	usd
	us-gaap	Interest Expense InterestExpense	1822000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	211000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	339000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1343000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	349000	usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.31
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.31
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	27000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	986000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	35937000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	978000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-5013000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17692603	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17692603	shares
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31902000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	890000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-5415000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	27504000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	84936000	usd
CY2022Q1	exdx	Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes Value IssuanceOfStockFromVestedRestrictedStockUnitsAndPaymentOfEmployeesTaxesValue	115000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	231000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1376000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-10272000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	76156000	usd
CY2022Q2	exdx	Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes Value IssuanceOfStockFromVestedRestrictedStockUnitsAndPaymentOfEmployeesTaxesValue	107000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1440000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-14665000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	62824000	usd
CY2022Q3	exdx	Issuance Of Stock From Vested Restricted Stock Units And Payment Of Employees Taxes Value IssuanceOfStockFromVestedRestrictedStockUnitsAndPaymentOfEmployeesTaxesValue	2000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	154000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1306000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-8096000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	56186000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-33033000	usd
	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1037000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	119000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	411000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	0	usd
	exdx	Non Cash Lease Expense NonCashLeaseExpense	738000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4122000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-33000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10967000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	985000	usd
	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-727000	usd
	exdx	Increase Decrease In Prepaid Expense And Current Other Assets IncreaseDecreaseInPrepaidExpenseAndCurrentOtherAssets	-921000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	120000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	100000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-767000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-613000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1422000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1061000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2000000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-121000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-22811000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26410000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	722000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3912000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-720000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3912000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	27000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	224000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	279000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	385000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	541000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	477000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	177000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	10000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10412000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-316000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-33943000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-30638000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62591000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99542000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1336000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1297000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	709000	usd
	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	250000	usd
	exdx	Equipment Purchased Under Notes Payable Obligations EquipmentPurchasedUnderNotesPayableObligations	0	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	81000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	645000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28400000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-273600000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risk and Uncertainties</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents and accounts receivable. Substantially all the Company's cash and cash equivalents are held at one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company has not experienced any losses on its cash or cash equivalents.</span></div>
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13416000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14726000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38783000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	32726000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28448000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	62391000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	200000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28648000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	62591000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2500000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	3700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2600000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-2500000	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	500000	usd
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	1300000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1200000	usd
	us-gaap	Advertising Expense AdvertisingExpense	2200000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2994617	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3052363	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q3	us-gaap	Other Assets Current OtherAssetsCurrent	2239000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1795000	usd
CY2023Q3	us-gaap	Prepaid Royalties PrepaidRoyalties	38000	usd
CY2022Q4	us-gaap	Prepaid Royalties PrepaidRoyalties	40000	usd
CY2023Q3	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	1120000	usd
CY2022Q4	exdx	Prepaid Maintenance And Insurance Contracts PrepaidMaintenanceAndInsuranceContracts	2072000	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	19000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	236000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3416000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4143000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	13700000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	13321000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	6486000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5124000	usd
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	7214000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	8197000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	600000	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	400000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1700000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1000000.0	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3666000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2355000	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	0	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	142000	usd
CY2023Q3	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	589000	usd
CY2022Q4	exdx	Accrued Purchase Goods And Services Current AccruedPurchaseGoodsAndServicesCurrent	803000	usd
CY2023Q3	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	281000	usd
CY2022Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	514000	usd
CY2023Q3	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	118000	usd
CY2022Q4	exdx	Accrued Liabilities Clinical Study Current AccruedLiabilitiesClinicalStudyCurrent	162000	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	535000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	700000	usd
CY2023Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	700000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	0	usd
CY2023Q3	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	302000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	445000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	872000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	226000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7063000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5347000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	487000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	1954000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1974000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	21239000	usd
CY2023Q3	exdx	Long Term Debt Including Undiscounted Interest LongTermDebtIncludingUndiscountedInterest	25654000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	124000	usd
CY2023Q3	exdx	Long Term Debt Undiscounted Interest Amount LongTermDebtUndiscountedInterestAmount	6076000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	19454000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	261000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	19193000	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	6900000	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	8000000.0	usd
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	9200000	usd
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1214059	shares
	exdx	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	0	shares
CY2023Q3	exdx	Stock Issued During Period Shares Warrants Exercised Net StockIssuedDuringPeriodSharesWarrantsExercisedNet	0	shares
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	200000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	890000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1306000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2854000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4122000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	900000	usd

Files In Submission

Name	View Source	Status
0001274737-23-000103-index-headers.html	Edgar Link	pending
0001274737-23-000103-index.html	Edgar Link	pending
0001274737-23-000103.txt	Edgar Link	pending
0001274737-23-000103-xbrl.zip	Edgar Link	pending
a1221libertywayassignmenta.htm	Edgar Link	pending
exagen-clawbackpolicy.htm	Edgar Link	pending
exdx-20230930.htm	Edgar Link	pending
exdx-20230930.xsd	Edgar Link	pending
exdx-20230930_cal.xml	Edgar Link	unprocessable
exdx-20230930_def.xml	Edgar Link	unprocessable
exdx-20230930_lab.xml	Edgar Link	unprocessable
exdx-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
exdx-20230930_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
image10a.jpg	Edgar Link	pending
image11a.jpg	Edgar Link	pending
image12a.jpg	Edgar Link	pending
image13a.jpg	Edgar Link	pending
image14a.jpg	Edgar Link	pending
image15a.jpg	Edgar Link	pending
image16a.jpg	Edgar Link	pending
image17a.jpg	Edgar Link	pending
image18a.jpg	Edgar Link	pending
image19a.jpg	Edgar Link	pending
image1a.jpg	Edgar Link	pending
image20a.jpg	Edgar Link	pending
image21a.jpg	Edgar Link	pending
image22a.jpg	Edgar Link	pending
image23a.jpg	Edgar Link	pending
image24a.jpg	Edgar Link	pending
image25a.jpg	Edgar Link	pending
image26a.jpg	Edgar Link	pending
image27a.jpg	Edgar Link	pending
image28a.jpg	Edgar Link	pending
image29a.jpg	Edgar Link	pending
image2a.jpg	Edgar Link	pending
image30a.jpg	Edgar Link	pending
image31a.jpg	Edgar Link	pending
image32a.jpg	Edgar Link	pending
image33a.jpg	Edgar Link	pending
image34a.jpg	Edgar Link	pending
image35a.jpg	Edgar Link	pending
image3a.jpg	Edgar Link	pending
image4a.jpg	Edgar Link	pending
image5a.jpg	Edgar Link	pending
image6a.jpg	Edgar Link	pending
image7a.jpg	Edgar Link	pending
image8a.jpg	Edgar Link	pending
image9a.jpg	Edgar Link	pending
imagea.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xgn311-093023.htm	Edgar Link	pending
xgn312-093023.htm	Edgar Link	pending
xgn321-093023.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XGN
EXAGEN INC. Stock $xgn

2023 Q4 Form 10-Q Financial Statement

#000127473723000103 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN EXAGEN INC. Stock $xgn

2023 Q4 Form 10-Q Financial Statement

#000127473723000103 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XGN
EXAGEN INC. Stock $xgn